(Q33194915)

23 July 2017

1 reference

title

Pharmacologic therapy for diabetic retinopathy (English)

1 reference

23 July 2017

1 reference

Matthew A Speicher

1

1 reference

23 July 2017

Ronald P Danis

series ordinal

2

1 reference

23 July 2017

Mark Criswell

series ordinal

3

1 reference

23 July 2017

Linda Pratt

series ordinal

4

1 reference

23 July 2017

language of work or name

English

0 references

publication date

1 May 2003

1 reference

Expert Opinion on Emerging Drugs

23 July 2017

1 reference

23 July 2017

8

1 reference

23 July 2017

1

1 reference

23 July 2017

239-250

1 reference

23 July 2017

Diseases of the retina

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.239

Influence of pericytes on capillary endothelial cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.239

Retinal and choroidal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.239

Barriers to compliance with screening guidelines for diabetic retinopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.239

Progression of incipient diabetic retinopathy during good glycemic control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.239

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.239

Renin, prorenin, and immunoreactive renin in vitreous fluid from eyes with and without diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.239

Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with diabetic macular edema and other retinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.239

Angiotensin converting enzyme inhibiting therapy is associated with lower vitreous vascular endothelial growth factor concentrations in patients with proliferative diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.239

Circulating plasma vascular endothelial growth factor and microvascular complications of type 1 diabetes mellitus: the influence of ACE inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.239

The angiotensin II receptor antagonist candesartan cilexetil (TCV-116) ameliorates retinal disorders in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.239

The DIabetic Retinopathy Candesartan Trials (DIRECT) Programme, rationale and study design

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.239

Aldose reductase inhibition prevents glucose-induced apoptosis in cultured bovine retinal microvascular pericytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.239

VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.239

Protein kinase C activation and the development of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.239

Abnormalities of retinal metabolism in diabetes or experimental galactosemia: V. Relationship between protein kinase C and ATPases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.239

Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1alpha and VEGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.239

Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.239

Hydrocortisone decreases retinal endothelial cell water and solute flux coincident with increased content and decreased phosphorylation of occludin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.239

Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.239

Targeting vascular endothelial growth factor (VEGF) for anti-tumor therapy, by anti-VEGF neutralizing monoclonal antibodies or by VEGF receptor tyrosine-kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.239

Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.239

Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.239

Clinical strategy for the development of angiogenesis inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.239

Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.239

Receptors and growth-promoting effects of insulin and insulinlike growth factors on cells from bovine retinal capillaries and aorta

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.239

A follow-up study of vascular disease in growth-hormone-deficient dwarfs with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.239

Pharmacokinetics, pharmacodynamics, and safety of microencapsulated octreotide acetate in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.239

Octreotide reduces vitreous hemorrhage and loss of visual acuity risk in patients with high-risk proliferative diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.239

The efficacy of octreotide in the therapy of severe nonproliferative and early proliferative diabetic retinopathy: a randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.239

Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.239

Pigment epithelium-derived factor protects cultured retinal pericytes from advanced glycation end product-induced injury through its antioxidative properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.239

Upregulation of pigment epithelium-derived factor after laser photocoagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.239

Gelatinase B in proliferative vitreoretinal disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.239

Efficacy of Prinomastat) (AG3340), a matrix metalloprotease inhibitor, in treatment of retinal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.239

A possible mechanism for inhibition of angiogenesis by angiostatic steroids: induction of capillary basement membrane dissolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.239

Intravitreal triamcinolone acetonide inhibits choroidal neovascularization in a laser-treated rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.239

ICGA-guided laser photocoagulation of occult choroidal neovascularization in age-related macular degeneration. Indocyanine green angiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.239

Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.239

Dramatic inhibition of retinal and choroidal neovascularization by oral administration of a kinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.239

(S)-13-[(dimethylamino)methyl]-10,11,14,15-tetrahydro-4,9:16, 21-dimetheno-1H, 13H-dibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecene-1,3(2H)-d ione (LY333531) and related analogues: isozyme selective inhibitors of protein kinase C beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.239

Alterations in protein tyrosine kinase pathways following retinal vein occlusion in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.239

21 January 2018

Identifiers

DOI

10.1517/14728214.8.1.239

1 reference

23 July 2017

1 reference